Literature DB >> 23661729

AIDS research. More woes for struggling HIV vaccine field.

Jon Cohen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23661729     DOI： 10.1126/science.340.6133.667

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  22 in total

1.  Programming CMV for vaccine vector design.

Authors:  Srinika Ranasinghe; Bruce D Walker
Journal:  Nat Biotechnol       Date:  2013-09       Impact factor: 54.908

Review 2.  The role of glycans in immune evasion: the human fetoembryonic defence system hypothesis revisited.

Authors:  Gary F Clark
Journal:  Mol Hum Reprod       Date:  2013-09-15       Impact factor: 4.025

3.  CD46-mediated transduction of a species D adenovirus vaccine improves mucosal vaccine efficacy.

Authors:  Zenaido T Camacho; Mallory A Turner; Michael A Barry; Eric A Weaver
Journal:  Hum Gene Ther       Date:  2014-04-10       Impact factor: 5.695

4.  Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles.

Authors:  Paul A Goepfert; Marnie L Elizaga; Kelly Seaton; Georgia D Tomaras; David C Montefiori; Alicia Sato; John Hural; Stephen C DeRosa; Spyros A Kalams; M Juliana McElrath; Michael C Keefer; Lindsey R Baden; Javier R Lama; Jorge Sanchez; Mark J Mulligan; Susan P Buchbinder; Scott M Hammer; Beryl A Koblin; Michael Pensiero; Chris Butler; Bernard Moss; Harriet L Robinson
Journal:  J Infect Dis       Date:  2014-01-07       Impact factor: 5.226

5.  Gene-based neonatal immune priming potentiates a mucosal adenoviral vaccine encoding mycobacterial Ag85B.

Authors:  Guixiang Dai; Hamada F Rady; Weitao Huang; Judd E Shellito; Carol Mason; Alistair J Ramsay
Journal:  Vaccine       Date:  2016-11-04       Impact factor: 3.641

Review 6.  Novel directions in HIV-1 vaccines revealed from clinical trials.

Authors:  Jean-Louis Excler; Georgia D Tomaras; Nina D Russell
Journal:  Curr Opin HIV AIDS       Date:  2013-09       Impact factor: 4.283

7.  Viremic HIV Controllers Exhibit High Plasmacytoid Dendritic Cell-Reactive Opsonophagocytic IgG Antibody Responses against HIV-1 p24 Associated with Greater Antibody Isotype Diversification.

Authors:  M Christian Tjiam; James P A Taylor; Mazmah A Morshidi; Lucy Sariputra; Sally Burrows; Jeffrey N Martin; Steven G Deeks; Dino B A Tan; Silvia Lee; Sonia Fernandez; Martyn A French
Journal:  J Immunol       Date:  2015-04-24       Impact factor: 5.422

8.  Enhanced Recognition of HIV-1 Cryptic Epitopes Restricted by HLA Class I Alleles Associated With a Favorable Clinical Outcome.

Authors:  Anju Bansal; Tiffanie Mann; Sarah Sterrett; Binghao J Peng; Anne Bet; Jonathan M Carlson; Paul A Goepfert
Journal:  J Acquir Immune Defic Syndr       Date:  2015-09-01       Impact factor: 3.731

9.  Social justice and HIV vaccine research in the age of pre-exposure prophylaxis and treatment as prevention.

Authors:  Theodore C Bailey; Jeremy Sugarman
Journal:  Curr HIV Res       Date:  2013-09       Impact factor: 1.581

10.  HIV-1-Specific CD8 T Cells Exhibit Limited Cross-Reactivity during Acute Infection.

Authors:  Victor Y Du; Anju Bansal; Jonathan Carlson; Jesus F Salazar-Gonzalez; Maria G Salazar; Kristin Ladell; Stephanie Gras; Tracy M Josephs; Sonya L Heath; David A Price; Jamie Rossjohn; Eric Hunter; Paul A Goepfert
Journal:  J Immunol       Date:  2016-03-16       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.